1. Home
  2. ZUMZ vs ASMB Comparison

ZUMZ vs ASMB Comparison

Compare ZUMZ & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zumiez Inc.

ZUMZ

Zumiez Inc.

N/A

Current Price

$23.54

Market Cap

421.7M

ML Signal

N/A

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

N/A

Current Price

$28.43

Market Cap

440.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ZUMZ
ASMB
Founded
1978
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
421.7M
440.0M
IPO Year
2005
2010

Fundamental Metrics

Financial Performance
Metric
ZUMZ
ASMB
Price
$23.54
$28.43
Analyst Decision
Hold
Strong Buy
Analyst Count
1
6
Target Price
$18.00
$43.40
AVG Volume (30 Days)
126.7K
92.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
97.23
50.00
EPS
N/A
N/A
Revenue
$889,202,000.00
N/A
Revenue This Year
$6.33
$33.33
Revenue Next Year
$1.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.57
N/A
52 Week Low
$11.31
$7.76
52 Week High
$31.70
$39.71

Technical Indicators

Market Signals
Indicator
ZUMZ
ASMB
Relative Strength Index (RSI) 42.11 49.43
Support Level $21.19 $26.50
Resistance Level $27.31 $30.66
Average True Range (ATR) 1.23 1.46
MACD -0.25 0.06
Stochastic Oscillator 38.10 45.30

Price Performance

Historical Comparison
ZUMZ
ASMB

About ZUMZ Zumiez Inc.

Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: